(Q44041871)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23382484%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

title

Phosphodiesterase type 5 inhibition improves arterial stiffness after exercise but not exercise capacity in hypertensive men (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23382484%20AND%20SRC:MED&resulttype=core&format=json

Lorenzo Salvatore Malatino

23 February 2020

author

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23382484%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

author name string

Teresa M Attinà

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23382484%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Iain D Drummond

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23382484%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Simon R Maxwell

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23382484%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

David J Webb

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23382484%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

publication date

7 January 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23382484%20AND%20SRC:MED&resulttype=core&format=json

Journal of Clinical Hypertension

23 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23382484%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23382484%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23382484%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

page(s)

342-350

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23382484%20AND%20SRC:MED&resulttype=core&format=json

Impaired exercise tolerance in hypertensive patients

23 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FAJH%2FHPS057

Exercise capacity and mortality among men referred for exercise testing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJH%2FHPS057

Exercise reduces arterial pressure augmentation through vasodilation of muscular arteries in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJH%2FHPS057

Pulse pressure and endothelial dysfunction in never-treated hypertensive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJH%2FHPS057

Recent advances in arterial stiffness and wave reflection in human hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJH%2FHPS057

Exaggerated exercise blood pressure is related to impaired endothelial vasodilator function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJH%2FHPS057

Exercise blood pressure response, albuminuria, and arterial stiffness in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJH%2FHPS057

Nitric oxide regulates local arterial distensibility in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJH%2FHPS057

Cyclic GMP phosphodiesterases and regulation of smooth muscle function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJH%2FHPS057

Overview of PDEs and their regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJH%2FHPS057

Sildenafil citrate therapy for pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJH%2FHPS057

Sildenafil improves exercise hemodynamics and oxygen uptake in patients with systolic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJH%2FHPS057

PDE5 inhibition with sildenafil improves left ventricular diastolic function, cardiac geometry, and clinical status in patients with stable systolic heart failure: results of a 1-year, prospective, randomized, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJH%2FHPS057

Clinical potential of combined organic nitrate and phosphodiesterase type 5 inhibitor in treatment-resistant hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJH%2FHPS057

Blood pressure lowering effects of a new long-acting inhibitor of phosphodiesterase 5 in patients with mild to moderate hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJH%2FHPS057

Phosphodiesterase type 5 inhibition reverses impaired forearm exercise-induced vasodilatation in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJH%2FHPS057

Accuracy of automated auscultatory blood pressure measurement during supine exercise and treadmill stress electrocardiogram-testing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJH%2FHPS057

Single and combined therapy for systemic hypertension with propranolol, hydralazine and hydrochlorothiazide: hemodynamic and neuroendocrine mechanisms of action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJH%2FHPS057

Comparative human pharmacokinetics and metabolism of single-dose oral and intravenous sildenafil

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJH%2FHPS057

The effects of phosphodiesterase-5 inhibition with sildenafil on pulmonary hemodynamics and diffusion capacity, exercise ventilatory efficiency, and oxygen uptake kinetics in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJH%2FHPS057

Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJH%2FHPS057

Sildenafil improves cardiac output and exercise performance during acute hypoxia, but not normoxia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJH%2FHPS057

Chronic administration of Sildenafil improves markers of endothelial function in men with Type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJH%2FHPS057

Sildenafil effects on exercise, neurohormonal activation, and erectile dysfunction in congestive heart failure: a double-blind, placebo-controlled, randomized study followed by a prospective treatment for erectile dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJH%2FHPS057

Oral sildenafil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension: comparison with inhaled nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJH%2FHPS057

Physical Fitness and All-Cause Mortality in Hypertensive Men

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJH%2FHPS057

21 January 2018

Identifiers

DOI

10.1093/AJH/HPS057

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23382484%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1 reference